Sunday , November 19 2017
Home / Tag Archives: non-alcoholic steatohepatitis

Tag Archives: non-alcoholic steatohepatitis

October, 2017

April, 2017

September, 2016

  • 21 September

    Allergan Acquires Tobira Therapeutics for Up to $1.7 Billion

    DUBLIN and SAN FRANCISCO, Sept. 20, 2016 /PRNewswire/ — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Tobira Therapeutics, Inc. (NASDAQ: TBRA), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for non-alcoholic steatohepatitis (NASH) and other liver diseases, today announced that they have entered into a …